Literature DB >> 17602717

Glomerular nephrotoxicity of aminoglycosides.

Carlos Martínez-Salgado1, Francisco J López-Hernández, José M López-Novoa.   

Abstract

Aminoglycoside antibiotics are the most commonly used antibiotics worldwide in the treatment of Gram-negative bacterial infections. However, aminoglycosides induce nephrotoxicity in 10-20% of therapeutic courses. Aminoglycoside-induced nephrotoxicity is characterized by slow rises in serum creatinine, tubular necrosis and marked decreases in glomerular filtration rate and in the ultrafiltration coefficient. Regulation of the ultrafiltration coefficient depends on the activity of intraglomerular mesangial cells. The mechanisms responsible for tubular nephrotoxicity of aminoglycosides have been intensively reviewed previously, but glomerular toxicity has received less attention. The purpose of this review is to critically assess the published literature regarding the toxic mechanisms of action of aminoglycosides on renal glomeruli and mesangial cells. The main goal of this review is to provide an actualized and mechanistic vision of pathways involved in glomerular toxic effects of aminoglycosides.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17602717     DOI: 10.1016/j.taap.2007.05.004

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  51 in total

1.  Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury.

Authors:  Yan Yu; Hong Jin; Daniel Holder; Josef S Ozer; Stephanie Villarreal; Paul Shughrue; Shu Shi; David J Figueroa; Holly Clouse; Ming Su; Nagaraja Muniappa; Sean P Troth; Wendy Bailey; John Seng; Amy G Aslamkhan; Douglas Thudium; Frank D Sistare; David L Gerhold
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

2.  Prophylactic use of gentamicin/flucloxacillin versus cefuroxime in surgery: a meta analysis of clinical studies.

Authors:  Shaoning Luo; Yu Lai; Chunxin Liu; Yi Chen; Xiaoyu Qiao
Journal:  Int J Clin Exp Med       Date:  2015-10-15

3.  Section 3: Prevention and Treatment of AKI.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-03

Review 4.  Aminoglycoside modifying enzymes.

Authors:  Maria S Ramirez; Marcelo E Tolmasky
Journal:  Drug Resist Updat       Date:  2010-09-15       Impact factor: 18.500

5.  Aminoglycoside induced nephrotoxicity: molecular modeling studies of calreticulin-gentamicin complex.

Authors:  Gururao Hariprasad; Manoj Kumar; Komal Rani; Punit Kaur; Alagiri Srinivasan
Journal:  J Mol Model       Date:  2011-11-16       Impact factor: 1.810

6.  Effect of Helichrysum plicatum DC. subsp. plicatum ethanol extract on gentamicin-induced nephrotoxicity in rats.

Authors:  Betul Apaydin Yildirim; Saban Kordali; Kubra Asena Terim Kapakin; Fatih Yildirim; Esra Aktas Senocak; Serdar Altun
Journal:  J Zhejiang Univ Sci B       Date:  2017-06       Impact factor: 3.066

7.  In vitro readthrough of termination codons by gentamycin in the Stüve-Wiedemann Syndrome.

Authors:  Samuel Bellais; Carine Le Goff; Nathalie Dagoneau; Arnold Munnich; Valérie Cormier-Daire
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

8.  A histological study of the effect of exogenous melatonin on gentamicin induced structural alterations of proximal tubules in rats.

Authors:  Dina Kapić; Zakira Mornjaković; Esad Ćosović; Maida Šahinović
Journal:  Bosn J Basic Med Sci       Date:  2014-02       Impact factor: 3.363

9.  Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression.

Authors:  Valeria Cernaro; Alessandra Sfacteria; Claudia Rifici; Francesco Macrì; Giulia Maricchiolo; Antonio Lacquaniti; Carlo Alberto Ricciardi; Antoine Buemi; Giuseppe Costantino; Domenico Santoro; Michele Buemi
Journal:  J Nephrol       Date:  2016-09-27       Impact factor: 3.902

Review 10.  Fluid, electrolyte and acid-base disorders associated with antibiotic therapy.

Authors:  R Zietse; R Zoutendijk; E J Hoorn
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.